Global Search

Hide Filters

Showing 2972 results

¿Cómo contactar con compras de Novartis?
Comment interagir avec le service Approvisionnement de Novartis?
Pulse Update / Jan 09, 2023

Novartis shares strategy insights and highlights key pipeline catalysts at JP Morgan Healthcare Conference 2023
Statement / Jan 09, 2023

Zolgensma Global Managed Access Program in 2023
Comment facturer Novartis?
¿Cómo facturar a Novartis?
Ad hoc release / Jul 19, 2022

Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance

Ad hoc announcement pursuant to Art. 53 LR Q2 sales grew +5% cc1 (-1% USD) Innovative Medicines (IM) sales grew +5% cc (-1% USD); strong performance of key growth brands including Entresto (+33%…
Press release / Jun 30, 2022

New Phase III data show Novartis tislelizumab significantly extended median overall survival by more than 6 months in first-line advanced esophageal cancer in combination with chemotherapy

First-line tislelizumab plus chemotherapy showed median overall survival of 17.2 months versus 10.6 months for chemotherapy and reduced risk of death by 34% in patients with advanced esophageal…
Press release / Jun 30, 2022

Novartis resumes production and delivery of radioligand therapy medicines ahead of schedule

Production and phased deliveries of patient doses resumed in early June Screening and enrollment have restarted for 177Lu-PSMA-617 and Lutathera® clinical trials Expanding radioligand therapy…
Press release / Nov 07, 2022

Sandoz announces further investment in key manufacturing facility in Austria, to support increased global demand for essential antibiotics

EUR 50m planned investment to support increased manufacturing capacity for finished dosage form penicillins, the leading class of antibiotics worldwideNew project brings total planned investment into…